Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.53 EUR
−36.62 M EUR
0.00 EUR
30.63 M
About Protara Therapeutics, Inc.
Sector
CEO
Jesse Shefferman
Headquarters
New York
Website
Founded
2006
FIGI
BBG00JRND593
Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1KPA is 4.98 EUR — it has increased by 0.40% in the past 24 hours. Watch PROTARA THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange PROTARA THERAPEUTICS INC stocks are traded under the ticker 1KPA.
1KPA stock has fallen by −11.07% compared to the previous week, the month change is a 130.56% rise, over the last year PROTARA THERAPEUTICS INC has showed a 213.21% increase.
We've gathered analysts' opinions on PROTARA THERAPEUTICS INC future price: according to them, 1KPA price has a max estimate of 47.59 EUR and a min estimate of 13.32 EUR. Watch 1KPA chart and read a more detailed PROTARA THERAPEUTICS INC stock forecast: see what analysts think of PROTARA THERAPEUTICS INC and suggest that you do with its stocks.
1KPA reached its all-time high on Aug 8, 2007 with the price of 403.60 EUR, and its all-time low was 1.04 EUR and was reached on Nov 24, 2023. View more price dynamics on 1KPA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1KPA stock is 8.87% volatile and has beta coefficient of 2.23. Track PROTARA THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is PROTARA THERAPEUTICS INC there?
Today PROTARA THERAPEUTICS INC has the market capitalization of 169.93 M, it has decreased by −10.05% over the last week.
Yes, you can track PROTARA THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
PROTARA THERAPEUTICS INC is going to release the next earnings report on Mar 5, 2025. Keep track of upcoming events with our Earnings Calendar.
1KPA earnings for the last quarter are −0.45 EUR per share, whereas the estimation was −0.47 EUR resulting in a 3.85% surprise. The estimated earnings for the next quarter are −0.49 EUR per share. See more details about PROTARA THERAPEUTICS INC earnings.
PROTARA THERAPEUTICS INC revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
1KPA net income for the last quarter is −10.08 M EUR, while the quarter before that showed −8.88 M EUR of net income which accounts for −13.45% change. Track more PROTARA THERAPEUTICS INC financial stats to get the full picture.
No, 1KPA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 27.00 employees. See our rating of the largest employees — is PROTARA THERAPEUTICS INC on this list?
Like other stocks, 1KPA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROTARA THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PROTARA THERAPEUTICS INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PROTARA THERAPEUTICS INC stock shows the buy signal. See more of PROTARA THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.